Atea Pharmaceuticals (AVIR) reported a net loss of $32.2 million, or $0.40 per basic and diluted share, for the third quarter ended September 30, 2026. The company held $191.2 million in cash, cash equivalents and marketable securities at quarter-end.
The company reported positive Phase 3 C-BEYOND results for its bemnifosbuvir/ruzasvir regimen in hepatitis C and said Phase 3 C-FORWARD topline results remain expected in early 2027.
- Research and development expense was $27.1 million, down from $38.3 million a year earlier.
- General and administrative expense was $6.9 million, compared with $7.2 million in the prior-year quarter.
- Atea entered a Hercules Capital credit facility of up to $200 million and drew $65 million at closing on November 6, 2026.
- The company said its current resources are expected to fund planned operations into mid-2028.
- C-BEYOND reported a 93.91% sustained virologic response rate for BEM/RZR versus 94.75% for Epclusa in the modified intent-to-treat population.
$AVIR Hedge Fund Activity
We have seen 63 institutional investors add shares of $AVIR stock to their portfolio, and 54 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 945,918 shares (+inf%) to their portfolio in Q2 2026, for an estimated $4,398,518
- CURATED WEALTH PARTNERS LLC removed 695,000 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $3,620,950
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 610,607 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,839,322
- JANE STREET GROUP, LLC removed 418,296 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $1,945,076
- TWO SIGMA INVESTMENTS, LP removed 357,467 shares (-19.2%) from their portfolio in Q2 2026, for an estimated $1,662,221
- ACADIAN ASSET MANAGEMENT LLC added 303,079 shares (+14.9%) to their portfolio in Q3 2026, for an estimated $1,579,041
- IRENIC CAPITAL MANAGEMENT LP removed 301,699 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $1,402,900
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.